File Download
  • No File Attached
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Alleles at the Nicastrin locus modify presenilin 1-deficiency phenotype
  • Basic View
  • Metadata View
  • XML View
TitleAlleles at the Nicastrin locus modify presenilin 1-deficiency phenotype
 
AuthorsRozmahel, R5 3 4
Mount, HTJ2 3
Chen, F3
Nguyen, V5 3
Huang, J5 3
Erdebil, S3
Liauw, J3
Yu, G3
Hasegawa, H3
Gu, Y3
Song, YQ3
Schmidt, SD1
Nixon, RA2 3
Mathews, PM1
Bergeron, C2 3
Fraser, P3
Westaway, D3
St GeorgeHyslop, P2 3
 
Issue Date2002
 
PublisherNational Academy of Sciences. The Journal's web site is located at http://www.pnas.org
 
CitationProceedings Of The National Academy Of Sciences Of The United States Of America, 2002, v. 99 n. 22, p. 14452-14457 [How to Cite?]
DOI: http://dx.doi.org/10.1073/pnas.222413999
 
AbstractPresenilin 1 (PS1), presenilin 2, and nicastrin form high molecular weight complexes that are necessary for the endoproteolysis of several type 1 transmembrane proteins, including amyloid precursor protein (APP) and the Notch receptor, by apparently similar mechanisms. The cleavage of the Notch receptor at the S3-site releases a C-terminal cytoplasmic fragment (Notch intracellular domain) that acts as the intracellular transduction molecule for Notch activation. Missense mutations in the presenilins cause familial Alzheimer's disease by augmenting the γ-secretase cleavage of APP and overproducing one of the proteolytic derivatives, the Aβ peptide. Null mutations in PS1 inhibit both γ-secretase cleavage of APP and S3-site cleavage of the Notch receptor. Mice lacking PS1 function have defective Notch signaling and die perinatally with severe skeletal and brain deformities. We report here that a genetic modifier on mouse distal chromosome 1, coinciding with the locus containing Nicastrin, influences presenilin-mediated Notch S3-site cleavage and the resultant Notch phenotype without affecting presenilin-mediated APP γ-site cleavage. Two missense substitutions of residues conserved among vertebrates have been identified in nicastrin. These results indicate that Notch S3-site cleavage and APP γ-site cleavage are distinct presenilin-dependent processes and support a functional interaction between nicastrin and presenilins in vertebrates. The dissociation of Notch S3-site and APP γ-site cleavage activities will facilitate development of γ-secretase inhibitors for treatment of Alzheimer's disease.
 
ISSN0027-8424
2013 Impact Factor: 9.809
 
DOIhttp://dx.doi.org/10.1073/pnas.222413999
 
PubMed Central IDPMC137904
 
ISI Accession Number IDWOS:000178967400087
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorRozmahel, R
 
dc.contributor.authorMount, HTJ
 
dc.contributor.authorChen, F
 
dc.contributor.authorNguyen, V
 
dc.contributor.authorHuang, J
 
dc.contributor.authorErdebil, S
 
dc.contributor.authorLiauw, J
 
dc.contributor.authorYu, G
 
dc.contributor.authorHasegawa, H
 
dc.contributor.authorGu, Y
 
dc.contributor.authorSong, YQ
 
dc.contributor.authorSchmidt, SD
 
dc.contributor.authorNixon, RA
 
dc.contributor.authorMathews, PM
 
dc.contributor.authorBergeron, C
 
dc.contributor.authorFraser, P
 
dc.contributor.authorWestaway, D
 
dc.contributor.authorSt GeorgeHyslop, P
 
dc.date.accessioned2011-07-14T07:03:08Z
 
dc.date.available2011-07-14T07:03:08Z
 
dc.date.issued2002
 
dc.description.abstractPresenilin 1 (PS1), presenilin 2, and nicastrin form high molecular weight complexes that are necessary for the endoproteolysis of several type 1 transmembrane proteins, including amyloid precursor protein (APP) and the Notch receptor, by apparently similar mechanisms. The cleavage of the Notch receptor at the S3-site releases a C-terminal cytoplasmic fragment (Notch intracellular domain) that acts as the intracellular transduction molecule for Notch activation. Missense mutations in the presenilins cause familial Alzheimer's disease by augmenting the γ-secretase cleavage of APP and overproducing one of the proteolytic derivatives, the Aβ peptide. Null mutations in PS1 inhibit both γ-secretase cleavage of APP and S3-site cleavage of the Notch receptor. Mice lacking PS1 function have defective Notch signaling and die perinatally with severe skeletal and brain deformities. We report here that a genetic modifier on mouse distal chromosome 1, coinciding with the locus containing Nicastrin, influences presenilin-mediated Notch S3-site cleavage and the resultant Notch phenotype without affecting presenilin-mediated APP γ-site cleavage. Two missense substitutions of residues conserved among vertebrates have been identified in nicastrin. These results indicate that Notch S3-site cleavage and APP γ-site cleavage are distinct presenilin-dependent processes and support a functional interaction between nicastrin and presenilins in vertebrates. The dissociation of Notch S3-site and APP γ-site cleavage activities will facilitate development of γ-secretase inhibitors for treatment of Alzheimer's disease.
 
dc.description.naturelink_to_subscribed_fulltext
 
dc.identifier.citationProceedings Of The National Academy Of Sciences Of The United States Of America, 2002, v. 99 n. 22, p. 14452-14457 [How to Cite?]
DOI: http://dx.doi.org/10.1073/pnas.222413999
 
dc.identifier.doihttp://dx.doi.org/10.1073/pnas.222413999
 
dc.identifier.epage14457
 
dc.identifier.f10001010545
 
dc.identifier.isiWOS:000178967400087
 
dc.identifier.issn0027-8424
2013 Impact Factor: 9.809
 
dc.identifier.issue22
 
dc.identifier.pmcidPMC137904
 
dc.identifier.pmid12388777
 
dc.identifier.scopuseid_2-s2.0-0037195102
 
dc.identifier.spage14452
 
dc.identifier.urihttp://hdl.handle.net/10722/134767
 
dc.identifier.volume99
 
dc.publisherNational Academy of Sciences. The Journal's web site is located at http://www.pnas.org
 
dc.publisher.placeUnited States
 
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of America
 
dc.relation.referencesReferences in Scopus
 
dc.subject.mesh*Alleles
 
dc.subject.meshAmyloid Precursor Protein Secretases
 
dc.subject.meshAmyloid beta-Peptides/metabolism
 
dc.subject.meshAmyloid beta-Protein Precursor/metabolism
 
dc.subject.meshAnimals
 
dc.subject.meshAspartic Acid Endopeptidases
 
dc.subject.meshBinding Sites
 
dc.subject.meshBreeding
 
dc.subject.meshChromosome Mapping
 
dc.subject.meshEndopeptidases/metabolism
 
dc.subject.meshFemale
 
dc.subject.meshMale
 
dc.subject.meshMembrane Glycoproteins/*genetics
 
dc.subject.meshMembrane Proteins/genetics/*metabolism
 
dc.subject.meshMice
 
dc.subject.meshMice, Inbred C57BL
 
dc.subject.meshMice, Knockout
 
dc.subject.meshPeptide Fragments/metabolism
 
dc.subject.meshPhenotype
 
dc.subject.meshPresenilin-1
 
dc.subject.meshReceptors, Notch
 
dc.subject.meshSpine/*abnormalities
 
dc.titleAlleles at the Nicastrin locus modify presenilin 1-deficiency phenotype
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Rozmahel, R</contributor.author>
<contributor.author>Mount, HTJ</contributor.author>
<contributor.author>Chen, F</contributor.author>
<contributor.author>Nguyen, V</contributor.author>
<contributor.author>Huang, J</contributor.author>
<contributor.author>Erdebil, S</contributor.author>
<contributor.author>Liauw, J</contributor.author>
<contributor.author>Yu, G</contributor.author>
<contributor.author>Hasegawa, H</contributor.author>
<contributor.author>Gu, Y</contributor.author>
<contributor.author>Song, YQ</contributor.author>
<contributor.author>Schmidt, SD</contributor.author>
<contributor.author>Nixon, RA</contributor.author>
<contributor.author>Mathews, PM</contributor.author>
<contributor.author>Bergeron, C</contributor.author>
<contributor.author>Fraser, P</contributor.author>
<contributor.author>Westaway, D</contributor.author>
<contributor.author>St GeorgeHyslop, P</contributor.author>
<date.accessioned>2011-07-14T07:03:08Z</date.accessioned>
<date.available>2011-07-14T07:03:08Z</date.available>
<date.issued>2002</date.issued>
<identifier.citation>Proceedings Of The National Academy Of Sciences Of The United States Of America, 2002, v. 99 n. 22, p. 14452-14457</identifier.citation>
<identifier.issn>0027-8424</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/134767</identifier.uri>
<description.abstract>Presenilin 1 (PS1), presenilin 2, and nicastrin form high molecular weight complexes that are necessary for the endoproteolysis of several type 1 transmembrane proteins, including amyloid precursor protein (APP) and the Notch receptor, by apparently similar mechanisms. The cleavage of the Notch receptor at the S3-site releases a C-terminal cytoplasmic fragment (Notch intracellular domain) that acts as the intracellular transduction molecule for Notch activation. Missense mutations in the presenilins cause familial Alzheimer&apos;s disease by augmenting the &#947;-secretase cleavage of APP and overproducing one of the proteolytic derivatives, the A&#946; peptide. Null mutations in PS1 inhibit both &#947;-secretase cleavage of APP and S3-site cleavage of the Notch receptor. Mice lacking PS1 function have defective Notch signaling and die perinatally with severe skeletal and brain deformities. We report here that a genetic modifier on mouse distal chromosome 1, coinciding with the locus containing Nicastrin, influences presenilin-mediated Notch S3-site cleavage and the resultant Notch phenotype without affecting presenilin-mediated APP &#947;-site cleavage. Two missense substitutions of residues conserved among vertebrates have been identified in nicastrin. These results indicate that Notch S3-site cleavage and APP &#947;-site cleavage are distinct presenilin-dependent processes and support a functional interaction between nicastrin and presenilins in vertebrates. The dissociation of Notch S3-site and APP &#947;-site cleavage activities will facilitate development of &#947;-secretase inhibitors for treatment of Alzheimer&apos;s disease.</description.abstract>
<publisher>National Academy of Sciences. The Journal&apos;s web site is located at http://www.pnas.org</publisher>
<relation.ispartof>Proceedings of the National Academy of Sciences of the United States of America</relation.ispartof>
<subject.mesh>*Alleles</subject.mesh>
<subject.mesh>Amyloid Precursor Protein Secretases</subject.mesh>
<subject.mesh>Amyloid beta-Peptides/metabolism</subject.mesh>
<subject.mesh>Amyloid beta-Protein Precursor/metabolism</subject.mesh>
<subject.mesh>Animals</subject.mesh>
<subject.mesh>Aspartic Acid Endopeptidases</subject.mesh>
<subject.mesh>Binding Sites</subject.mesh>
<subject.mesh>Breeding</subject.mesh>
<subject.mesh>Chromosome Mapping</subject.mesh>
<subject.mesh>Endopeptidases/metabolism</subject.mesh>
<subject.mesh>Female</subject.mesh>
<subject.mesh>Male</subject.mesh>
<subject.mesh>Membrane Glycoproteins/*genetics</subject.mesh>
<subject.mesh>Membrane Proteins/genetics/*metabolism</subject.mesh>
<subject.mesh>Mice</subject.mesh>
<subject.mesh>Mice, Inbred C57BL</subject.mesh>
<subject.mesh>Mice, Knockout</subject.mesh>
<subject.mesh>Peptide Fragments/metabolism</subject.mesh>
<subject.mesh>Phenotype</subject.mesh>
<subject.mesh>Presenilin-1</subject.mesh>
<subject.mesh>Receptors, Notch</subject.mesh>
<subject.mesh>Spine/*abnormalities</subject.mesh>
<title>Alleles at the Nicastrin locus modify presenilin 1-deficiency phenotype</title>
<type>Article</type>
<description.nature>link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1073/pnas.222413999</identifier.doi>
<identifier.pmid>12388777</identifier.pmid>
<identifier.pmcid>PMC137904</identifier.pmcid>
<identifier.scopus>eid_2-s2.0-0037195102</identifier.scopus>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-0037195102&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>99</identifier.volume>
<identifier.issue>22</identifier.issue>
<identifier.spage>14452</identifier.spage>
<identifier.epage>14457</identifier.epage>
<identifier.isi>WOS:000178967400087</identifier.isi>
<publisher.place>United States</publisher.place>
<identifier.f1000>1010545</identifier.f1000>
</item>
Author Affiliations
  1. New York University Langone Medical Center
  2. Queens Health Network
  3. University of Toronto
  4. University of Alabama
  5. Hospital for Sick Children University of Toronto